Single-Access
Overview
Complex High Risk-PCI cases that are treated with devices via dual/multiple access sites present challenges and risk due to the increased likelihood of vascular complications and bleeding1 . Utilizing the single access technique with Impella® with the right patient at the right time could lead to less vascular complications and bleeding.1-4
Hear from Jason Wollmuth, MD, FACC about his experience with Impella Single-Access
Additional Resources
References
- Gajanan G, et al. 2022 J Invasive Cardiol. 34(3):E190-E195
- Wollmuth J, et al. 2021 Cardiovasc Revasc Med 285:59-549. Abstract 1146
- Wollmuth J, et al. 2020 Catheter Cardiovasc Interv. 96(1):114-116. doi: 10.1002/ccd.28556
- Kopin D, et al. 2019 JACC Cardiovasc Interv. 12(22):2247-2256. doi: 10.1016/j.jcin.2019.05.051
NPS-4221